Literature DB >> 12772242

Sterile inflammation associated with transradial catheterization and hydrophilic sheaths.

Mark Kozak1, David R Adams, Michael D Ioffreda, Michelle J Nickolaus, Thomas J Seery, Charles E Chambers, Steven M Ettinger, Patrick H McNulty, Ian C Gilchrist.   

Abstract

In 1999, we noted the development of inflammation and/or abscesses at the site of radial access in a group of patients. Over a 3-year period, we noted this inflammation in 33 patients out of 2,038 (1.6%) who had catheterization via the radial approach. The radial abscesses occurred in 30 patients out of 1,063 (2.8%) in whom we could confirm the use of a hydrophilic-coated sheath, but in no patient for whom we can document that an uncoated sheath was used. No infectious agent could be implicated, and the time course for the development of the abscess, typically 2 to 3 weeks, seemed long for a bacterial infection. Later patients had biopsies, and granulomatous reactions were seen in most. Additionally, a few of the biopsies showed an amorphous extravascular substance consistent with the catheter coating. All patients had good long-term outcomes. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12772242     DOI: 10.1002/ccd.10522

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  19 in total

1.  Foreign Body Emboli following Cerebrovascular Interventions: Clinical, Radiographic, and Histopathologic Features.

Authors:  M Shapiro; M D Ollenschleger; C Baccin; T Becske; G R Spiegel; Y Wang; X Song; E Raz; D Zumofen; M B Potts; P K Nelson
Journal:  AJNR Am J Neuroradiol       Date:  2015-08-20       Impact factor: 3.825

2.  Identification and management of complications of transradial procedures.

Authors:  Adhir Shroff; Saifullah Siddiqui; Aaron Burg; Ish Singla
Journal:  Curr Cardiol Rep       Date:  2013-04       Impact factor: 2.931

3.  Suspected cerebral foreign body granuloma following endovascular treatment of intracranial aneurysm: imaging features.

Authors:  David Minks; Dennis Briley; Ursula Schulz; Wilhelm Küker
Journal:  Neuroradiology       Date:  2014-10-03       Impact factor: 2.804

4.  Enhancing brain lesions after endovascular treatment of aneurysms.

Authors:  J P Cruz; T Marotta; C O'Kelly; M Holtmannspötter; G Saliou; R Willinsky; T Krings; R Agid
Journal:  AJNR Am J Neuroradiol       Date:  2014-05-29       Impact factor: 3.825

5.  Hydrophilic Polymer Embolism: An Update for Physicians.

Authors:  Rashi I Mehta; Rupal I Mehta
Journal:  Am J Med       Date:  2017-02-16       Impact factor: 4.965

6.  Transradial coronary angiography in children and adolescents.

Authors:  Claire Irving; Azfar Zaman; Richard Kirk
Journal:  Pediatr Cardiol       Date:  2009-08-11       Impact factor: 1.655

7.  Particulates from hydrophilic-coated guiding sheaths embolise to the brain.

Authors:  James R L Stanley; Abraham R Tzafriri; Kathryn Regan; Alan LaRochelle; Gee Wong; Brett G Zani; Peter M Markham; Lynn Bailey; Anna Spognardi; Gregory A Kopia; Elazer R Edelman
Journal:  EuroIntervention       Date:  2016-03       Impact factor: 6.534

8.  Intravascular polymer material after coil embolization of a giant cerebral aneurysm.

Authors:  Rupal I Mehta; Rashi I Mehta; Michael C Fishbein; Orestes E Solis; Reza Jahan; Noriko Salamon; Harry V Vinters; William H Yong
Journal:  Hum Pathol       Date:  2009-08-27       Impact factor: 3.466

9.  Hydrophilic-coated sheaths increase the success rate of transradial coronary procedures and reduce patient discomfort but do not reduce the occlusion rate: randomized single-blind comparison of coated vs. non-coated sheaths.

Authors:  Martin Kindel; Rudolf Rüppel
Journal:  Clin Res Cardiol       Date:  2008-03-31       Impact factor: 5.460

10.  A case of sheathless transradial coronary intervention for complex coronary lesions with a standard guiding catheter.

Authors:  Jaehuk Choi; Jon Suh; Hye-Sun Seo; Yoon Haeng Cho; Nae Hee Lee
Journal:  Korean Circ J       Date:  2013-05-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.